Reimagining the future of healthcare
ASHLEY / Huntington’s Disease Community Advocate
Press Releases
Subscribe to receive breaking news alerts about uniQure.
Subscribe-
-
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
-
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen